Skip to Content

IM Cannabis Corp IMCC

Morningstar Rating
$0.37 −0.02 (4.87%)
View Full Chart
Unlock Our Analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

IMCC is trading at a 57% discount.
Price
$0.37
Fair Value
$1.71
Uncertainty
Extreme
1-Star Price
$6.39
5-Star Price
$3.54
Economic Moat
Fvwg
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if IMCC is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.39
Day Range
$0.360.41
52-Week Range
$0.361.83
Bid/Ask
$0.37 / $0.41
Market Cap
$4.97 Mil
Volume/Avg
61,582 / 64,210

Key Statistics

Price/Earnings (Normalized)
0.18
Price/Sales
0.23
Dividend Yield
Dividend Yield (Forward)
Total Yield

Company Profile

IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel and recreational cannabis in Canada. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
153

Valuation

Metric
IMCC
Price/Earnings (Normalized)
0.18
Price/Book Value
1.01
Price/Sales
0.23
Price/Cash Flow
Price/Earnings
IMCC

Financial Strength

Metric
IMCC
Quick Ratio
0.58
Current Ratio
1.01
Interest Coverage
Quick Ratio
IMCC

Profitability

Metric
IMCC
Return on Assets (Normalized)
−23.30%
Return on Equity (Normalized)
−120.31%
Return on Invested Capital (Normalized)
−50.30%
Return on Assets
IMCC

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ABvfbn$83.5 Bil
MKKGY
Merck KGaA ADRCtwtfq$67.6 Bil
HLN
Haleon PLC ADRNvpr$37.5 Bil
VTRS
Viatris IncHqcpc$11.7 Bil
RDY
Dr Reddy's Laboratories Ltd ADRKbwpt$11.6 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRFjj$10.5 Bil
CTLT
Catalent IncCznnjgc$6.8 Bil
PRGO
Perrigo Co PLCNlrj$4.1 Bil
CURLF
Curaleaf Holdings IncTjxg$3.1 Bil
PBH
Prestige Consumer Healthcare IncWfdkxl$3.0 Bil